Search
for
Sort by
Research 841–870 of 1000+
- Reply to: “Tofacitinib for the treatment of severe alopecia areata and variants”
- Alopecia areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata: An Updated Review for 2023
- Common skin infections in children
- JAK Inhibitors for Treatment of Alopecia Areata
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Frontiers in alopecia areata pathobiology research
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- New and Emerging Therapies for Alopecia Areata
- TGFβ signaling regulates lipogenesis in human sebaceous glands cells
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Emerging Unconventional Therapies for Alopecia Areata
- Vitamin D and the Skin: A Review for Dermatologists
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Skin and metabolic syndrome: A review of the possible associations
- Comparative Study of Trichoscopic Features of Alopecia Areata between Adults and Children and between Different Body Parts (Scalp, Beard, Eyebrow, and Moustache)
- Gut microbiome, metabolome and alopecia areata
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Vitiligo—Current Treatment Options and Future Perspectives
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients